Insider · CIK 0001691218

Furey John

Reports to the SEC for 3 companies · SAN CARLOS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001691218

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	PCVXVaxcyte, Inc.A Award	Director	AAward	+2,265 sh	—	—	5,306
2026-06-15	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.4K sh	—	—	11,389
2025-06-12	PCVXVaxcyte, Inc.A Award	Director	AAward	+3,041 sh	—	—	3,041
2025-06-12	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.4K sh	—	—	15,372
2024-07-02	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.8K sh	—	—	16,760
2024-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+660K sh	—	—	660,000
2023-07-03	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+500K sh	—	—	500,000
2022-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+500K sh	—	—	500,000
2021-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+380K sh	—	—	379,788
2020-07-01	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+196K sh	—	—	196,186
2019-07-02	ADAPAdaptimmune Therapeutics PLC · Option to purchase Ordinary SharesA Award	Director	AAward	+241K sh	—	—	240,541
2018-04-20	Spark Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+6,723 sh	$49.74	+$334K	6,723
2018-04-20	Spark Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−6,723 sh	$82.50	−$555K	0
2018-04-20	Spark Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−6,723 sh	—	—	120,000
2018-04-18	Spark Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+11K sh	$49.74	+$547K	11,000
2018-04-18	Spark Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−11K sh	$82.53	−$908K	0
2018-04-18	Spark Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−11K sh	—	—	126,723
2018-04-17	Spark Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,277 sh	$49.74	+$113K	2,277
2018-04-17	Spark Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,277 sh	$82.50	−$188K	0
2018-04-17	Spark Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,277 sh	—	—	137,723
2018-04-12	Spark Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+20K sh	$49.74	+$995K	20,000
2018-04-12	Spark Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−20K sh	$77.51	−$1.55M	0
2018-04-12	Spark Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−20K sh	—	—	140,000
2018-01-18	Spark Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+35K sh	—	—	35,000
2018-01-18	Spark Therapeutics, Inc.Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+17.5K sh	—	—	17,500
2017-12-11	Spark Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−18 sh	$46.33	−$833.94	0
2017-12-08	Spark Therapeutics, Inc.P Purchase	Chief Operating Officer	PPurchase	+18 sh	$73.48	+$1,322.64	18
2016-12-01	Spark Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+160K sh	—	—	160,000

Recent filings

Accepted (ET)
Jun 164
Furey John0001691218-26-000002
SEC(opens sec.gov)
Jun 164
Furey John0001691218-25-000003
SEC(opens sec.gov)
Jul 34
Furey John0001649094-24-000031
SEC(opens sec.gov)
Jul 14
Furey John0001104659-24-076891
SEC(opens sec.gov)
Jul 34
Furey John0001104659-23-077670
SEC(opens sec.gov)
Jul 14
Furey John0001104659-22-076898
SEC(opens sec.gov)
Jul 24
Furey John0001104659-21-088971
SEC(opens sec.gov)
Jul 14
Furey John0001104659-20-079788
SEC(opens sec.gov)
Jul 34
Furey John0001104659-19-039324
SEC(opens sec.gov)
Apr 244
Furey John0001609351-18-000038
SEC(opens sec.gov)
Apr 194
Furey John0001609351-18-000032
SEC(opens sec.gov)

Companies

Address

C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300

SAN CARLOS, CA, 94070